Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
J Antimicrob Chemother ; 74(3): 722-730, 2019 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-30517632

RESUMO

OBJECTIVES: To assess the prevalence and patterns of pre-treatment HIV drug resistance (PDR) and HIV-1 subtype in infants from Argentina with exposure to different antiretroviral drugs (ARVs) for the prevention of mother-to-child transmission (PMTCT). PATIENTS AND METHODS: HIV-1 genotyping was performed in 115 infants (median age = 2.3 months) born between 2007 and 2014 to screen for drug resistance mutations (DRMs) before starting first-line ART. HIV-1 subtype was characterized by phylogenetic and recombination analysis. RESULTS: Overall, DRMs were found in 34 of 115 infants (PDR level 30% to any ARV, 3.5% to PIs, 12% to NRTIs and 22% to NNRTIs). Of the 115 infants, 22 (19.1%) were ARV-unexposed. Another 93 were ARV-exposed: 28 (24.3%) to short-course zidovudine monotherapy ARV prophylaxis; 25 (21.7%) to nevirapine-based ARV prophylaxis; 12 (10.4%) to perinatal infant zidovudine prophylaxis + maternal combination ART with NNRTIs; and 28 (24.3%) to perinatal infant zidovudine prophylaxis+maternal combination ART with PIs. Transmitted drug resistance among ARV-unexposed infants was 32% (5% to PIs, 9% to NRTIs and 18% to NNRTIs). ART-exposed infants showed multi-class ARV resistance. Importantly, vertical transmission of a triple-class-resistant virus was confirmed in one case. Patterns of DRMs predicted high-level resistance to NNRTIs in a similar and high proportion (>50%) of infants with at least one DRM independently of ARV exposure. BF recombinants were found in 74%, subtype B in 20%, subtype C in 3% and novel AG and AB recombinants in 3%. CONCLUSIONS: PDR in HIV-1-infected children from Argentina is among the highest reported, jeopardizing successful lifelong suppressive ART as well as the efficacy of current PMTCT regimens.


Assuntos
Farmacorresistência Viral , Infecções por HIV/prevenção & controle , Infecções por HIV/virologia , HIV-1/genética , Transmissão Vertical de Doenças Infecciosas/prevenção & controle , Fármacos Anti-HIV/farmacologia , Fármacos Anti-HIV/uso terapêutico , Argentina/epidemiologia , Feminino , Genótipo , Infecções por HIV/epidemiologia , Infecções por HIV/transmissão , HIV-1/efeitos dos fármacos , Humanos , Lactente , Masculino , Mutação , Prevalência , Vigilância em Saúde Pública , Fatores de Risco , Produtos do Gene pol do Vírus da Imunodeficiência Humana
2.
Rev. Fac. Med. (Guatemala) ; 1(16): 6-7, ene.-jun. 2013. tab
Artigo em Espanhol | LILACS | ID: lil-734135

RESUMO

Introducción: se ha sugerido que la lactancia materna juega un rol importante en la prevención de obesidad infantil si se da de forma exclusiva durante los primeros 6 meses de vida. El motivo principal de este estudio fue el de investigar esta posible relación en una población de niños de 3 a 5 años de edad. Métodos: por medio de encuestas se determinó el tipo de alimentación durante los primeros 6 meses de vida de 150 niños de 3 a 5 años de edad. Los niños fueron pesados, medidos y se clasificaron según el percentil correspondiente a su Indice de Masa Corporal (IMC). Se analizaron los datos utilizando ANOVA...


Assuntos
Pré-Escolar , Aleitamento Materno , Leite Humano/fisiologia , Obesidade/prevenção & controle , Peso Corporal/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...